Barclays Increases Axon Enterprise (NASDAQ:AXON) Price Target to $381.00
Axon Enterprise (NASDAQ:AXON – Get Free Report) had its price objective lifted by investment analysts at Barclays from $308.00 to $381.00 in a report released on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the biotechnology company’s...
